APOE and Alzheimer disease: In the future, it will be important to evaluate AVAS efficacy in the context of the universal biological variables (UBV) of AD risk, specifically age, APOE, and sex, thus understanding the effect of AVAS in the presence of apoE3 vs. apoE4, using both male and female and young vs. old EFAD mice.